ASBMB Annual Meeting

Kountz tracks methyls in microbe metabolism

Meet a JBC Herbert Tabor Early Career Investigator Award winner
Courtney Chandler
March 12, 2021

Duncan Kountz became interested in microbial biochemistry through a seemingly standard source: a textbook. But this wasn't a textbook assigned for class or research — he chose it himself because it seemed interesting, a habit he started in high school.

Kountz-430x430.jpg
Duncan Kountz

"Textbooks help me expand what I'm exposed to," Kountz said, "and I find them perfectly tolerable as long as they're on a subject I'm interested in."

The habit helped him prepare for a career in science, which he knew he wanted to pursue from the time he was in high school. Following a family legacy, he attended Ohio State University and sought research opportunities. He started out in a developmental biology lab, but that textbook, "The Physiology and Biochemistry of Prokaryotes," inspired a move to microbial metabolism. He contacted Joseph Krzycki, an OSU researcher in the field, and joined Krzycki's lab as a sophomore.

"Complexity and diversity really interest me, and I found that in microbial physiology, those are both on display," Kountz said. "Microbes may seem like they're a simple system, but they're also amenable to detailed work."

The Krzycki lab was finishing a project on an enzyme belonging to a superfamily of methyltransferases, and Kountz wanted to investigate similar enzymes in the context of the gut microbiome. He observed that a particular gut bacterium, Eubacterium limosum, encoded many of these enzymes and could utilize several unusual molecules for its growth. He focused on one in particular, carnitine, and tracked down the enzymes responsible for its metabolism.

His research shows how microbial metabolism can affect both microbial prosperity and the health of the human host, as carnitine metabolism can produce toxic byproducts. Kountz was excited about the findings, in part for this potential real-world applicability.

"I think we are really at the dawn of using microbes to solve problems," he said. "I'm excited about the idea of engineering or finding new microbes with interesting properties that we can exploit to make human life better."

Now a fourth-year Ph.D. student in Emily Balskus' lab at Harvard, Kountz said his textbook count currently exceeds 100.

Methyl-removing enzyme diverts toxin precursor

Gut bacteria can produce harmful compounds as a byproduct of their normal metabolism. Carnitine, a quaternary amine found abundantly in red meat, can lead to production of a toxin precursor called trimethylamine, or TMA, during digestion. TMA is converted in the liver to TMA oxide, a marker of cardiovascular disease.

Duncan Kountz and colleagues at Ohio State showed that the gut bacteria Eubacterium limosum can use carnitine as fuel, thereby potentially curbing TMA production. They also identified a new metabolite, called norcarnitine, produced by demethylation of carnitine.

Seeking to identify the enzymes involved in this metabolic transformation, Kountz noticed that E. limosum encoded many enzymes in the MttB superfamily. MttB proteins are involved in methyl transfer reactions.

Kountz characterized the enzymes involved in this pathway and identified a methyltransferase, MtcB, that demethylates carnitine and shuttles the product into pathways responsible for energy utilization and biogenesis.

The study highlights how metabolic activities in gut microbia may promote health by preventing production of toxin precursors.

Courtney Chandler

Courtney Chandler is a postdoctoral researcher at the University of Maryland, Baltimore, and an industry careers columnist for ASBMB Today.

Join the ASBMB Today mailing list

Sign up to get updates on articles, interviews and events.

Latest in People

People highlights or most popular articles

Moving from medical liaison to medical lead
Jobs

Moving from medical liaison to medical lead

April 23, 2021

Our industry careers columnist talked to Jason Howard, who works in the medical affairs department of Sanofi Genzyme, a company that develops therapies for patients with rare diseases.

Eternal memories and an overdue tribute — storing digital data in DNA
Art

Eternal memories and an overdue tribute — storing digital data in DNA

April 21, 2021

Researchers crowdsourced 10,000 images, stored them on synthetic DNA and then used them to create a portrait of Rosalind Franklin, an often overlooked star of DNA discovery.

Hanawalt, Nagata and Regev named AACR fellows
Member News

Hanawalt, Nagata and Regev named AACR fellows

April 19, 2021

The American Association for Cancer Research Academy recognizes scientists whose contributions have led to progress against cancer.

In memoriam: Robert Baldwin
In Memoriam

In memoriam: Robert Baldwin

April 19, 2021

“His research sped a shift in many biologists’ attention from organismic biology, the study of creatures great and small, to molecular biology"

Seeing is believing
Art

Seeing is believing

April 13, 2021

Three science illustrators discuss how they have merged their academic training in research with a lifelong interest in the visual arts.

A $1 million pledge, a faculty position and a Passano award
Member News

A $1 million pledge, a faculty position and a Passano award

April 12, 2021

Hazelbauer pledges $1 million to high school; McReynolds to join faculty at Penn State; Goldberg receives Passano award for medical science.